Federal Register / Vol. 62, No. 5 / Wednesday, January 8, 1997 / Notices 1119

TIME AND DATE: 11:00 a.m., Monday,

January 13, 1997.

PLACE: Marriner S. Eccles Federal

Reserve Board Building, C Street

entrance between 20th and 21st Streets,

NW., Washington, DC 20551.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

1. Personnel actions (appointments,

promotions, assignments, reassignments, and

salary actions) involving individual Federal

Reserve System employees.

2. Any items carried forward from a

previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION:

Mr. Joseph R. Coyne, Assistant to the

Board; (202) 452–3204. You may call

(202) 452–3207, beginning at

approximately 5 p.m. two business days

before this meeting, for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting.

Dated: January 3, 1997.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 97–458 Filed 1–6–97; 9:49 am]

BILLING CODE 6210–01–P

Sunshine Act Meeting

AGENCY HOLDING THE MEETING: Board of

Governors of the Federal Reserve

System Federal Register Citation of

Previous Announcement: 62 FR 408,

January 3, 1997.

PREVIOUSLY ANNOUNCED TIME AND DATE OF

THE MEETING: 10:45 a.m., Wednesday,

January 8, 1997.

CHANGES IN THE MEETING: Addition of the

following closed item(s) to the meeting:

Guidance on international supervisory

coordination.

CONTACT PERSON FOR MORE INFORMATION:

Mr. Joseph R. Coyne, Assistant to the

Board; (202) 452–3204.

Dated: January 3, 1997.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 97–459 Filed 1–6–97; 9:49 am]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Toxic Substances and

Disease Registry

Statement of Organization, Functions,

and Delegations of Authority

Part J (Agency for Toxic Substances

and Disease Registry) of the Statement

of Organization, Functions, and

Delegations of Authority of the

Department of Health and Human

Services (50 FR 25129–25130, dated

June 17, 1985, as amended most

recently at 61 FR 9710, dated March 11,

1996) is amended to reflect the

following organizational changes within

the Division of Health Education (DHE),

Agency for Toxic Substances and

Disease Registry (ATSDR): (1) Retitle the

Division of Health Education to the

Division of Health Education and

Promotion; (2) revise the functional

statement for DHE; and (3) establish a

substructure within the Division.

Delete the title and functional

statement for the Division of Health

Education (JB7) and insert the

following:

Division of Health Education and

Promotion (JB7). (1) Develops and

implements strategies and programs to

educate individuals, communities

(including underserved and minority),

and health care providers about the

health effects of hazardous substances

in the environment; (2) in collaboration

with other ATSDR programs, evaluates

the outcome and impact of public health

activities in communities affected or

potentially affected by hazardous wastes

sites or releases; (3) develops, delivers,

and evaluates health messages and

materials to increase public awareness,

promote the adoption of healthy

behaviors, and improve the quality of

life in communities exposed to

hazardous substances in the

environment; (4) works with Federal,

state, tribal governments, and local

health entities to develop, implement,

or facilitate health promotion strategies,

based on the scientific findings

developed through ATSDR programs,

for communities at risk, and particularly

susceptible populations (e.g., women,

children, minorities, and underserved

populations) at risk or exposure to

hazardous substances in the

environment; (5) provides the agency’s

leadership in developing and

implementing education, training, and

evaluation programs developed by

national health organizations; (6)

conducts activities that involve affected

communities in the development and

implementation of public health

strategies that address the health impact

of hazardous substances in their

environment; (7) develops and

disseminates health education materials

to meet the environmental health

information needs of communities and

health professionals; (8) conducts

qualitative and quantitative research of

strategies for site-specific health

education, promotion, and health risk

communication.

Office of the Director (JB71). (1) Plans,

directs, coordinates, evaluates, and

manages the operations of the Division

of Health Education and Promotion; (2)

develops goals and objectives and

provides leadership, formulates policy,

and provides guidance in program

planning and development; (3) provides

program management, administrative

and logistical support services for the

division; (4) coordinates division

activities with other components of

ATSDR, other Federal, state, and local

agencies, community groups, national

associations, and nonprofit

organizations; (5) oversees a quality

assurance and training program for the

division’s activities.

Communication and Research Branch

(JB72). (1) Develops and disseminates

innovative communications methods

and materials to enhance site-specific

public health and diverse populations

(e.g., women, children, minorities, and

underserved populations) at risk of

exposure to hazardous substances in the

environment; (2) conducts qualitative

and quantitative research to develop

model standards for defining sitespecific health risk communication

objectives and to measure performance

and outcomes; (3) coordinates the

division’s site-specific applied research

program.

Health Education Branch (JB73). (1)

Plans, directs, coordinates, evaluates,

and provides leadership in

environmental health education; (2)

develops effective health education

tools and applies these tools through

continuing education, curriculum

development, and advances in

information technology; (3) provides

environmental health education

expertise, resources, and training to

public health partners and

communities; (4) plans, implements,

and evaluates community involvement

strategies to advance health education,

promotion, and health risk

communication among populations

(e.g., women, children, minorities, and

underserved populations) at risk of

exposure to hazardous substances in the

environment; (5) conducts qualitative

and quantitative research of strategies

for site-specific health education.

Health Promotion Branch (JB74). (1)

Plans, coordinates, evaluates, and

manages the health promotion,

evaluation, and quality assurance

activities of the division and provides

support and technical advice to the

evaluation and assurance activities of

ATSDR; (2) develops strategies and

implements methods for evaluating the

outcome and impact of public health

activities undertaken by ATSDR in

communities exposed to hazardous
1120 Federal Register / Vol. 62, No. 5 / Wednesday, January 8, 1997 / Notices

waste sites and releases; (3) collaborates

with Federal, state, tribal governments,

and local health entities to develop,

implement, or coordinate public health

promotion actions based on the

scientific findings developed through

ATSDR programs for communities (e.g.,

children, women, minorities and

underserved populations) at risk of

exposure to hazardous substances in the

environment; (4) based on scientific

findings developed through ATSDR

programs, collaborates with individuals,

communities, and medical and public

health entities to promote

implementation of public health actions

to prevent or mitigate health impacts

from hazardous waste sites and releases;

(5) provides the agency’s leadership in

developing and implementing

education, training, and evaluation

programs developed by national health

organizations; (6) coordinates the

division’s management information

system; (7) conducts qualitative and

quantitative research to develop

innovative public health practice

strategies to identify and address

emerging public health issues associated

with hazardous substances from waste

sites or unplanned releases.

Dated: December 23, 1996.

David Satcher,

Administrator, Agency for Toxic Substances

and Disease Registry.

[FR Doc. 97–405 Filed 1–7–97; 8:45 am]

BILLING CODE 4160–70–M

Centers for Disease Control and

Prevention

National Vaccine Advisory Committee

(NVAC), Subcommittee on Vaccine

Safety, Subcommittee on Immunization

Coverage, Subcommittee on Future

Vaccines, and the Advisory

Commission on Childhood Vaccines

(ACCV), Subcommittee on Vaccine

Safety: Meetings

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following Federal

advisory committee meetings.

Name: National Vaccine Advisory

Committee (NVAC).

Times and Dates: 9 a.m.–2 p.m.,

January 13, 1997; 8:30 a.m.–12:45 p.m.,

January 14, 1997.

Place: Hubert H. Humphrey Building,

Room 503A, 200 Independence Avenue,

SW, Washington, DC 20201.

Status: Open to the public, limited

only by the space available.

Notice: In the interest of security, the

Department has instituted stringent

procedures for entrance to the Hubert H.

Humphrey Building by non-government

employees. Thus, persons without a

government identification card should

plan to arrive at the building each day

either between 8 and 8:30 a.m. or 12:30

and 1 p.m. so they can be escorted to the

meeting. Entrance to the meeting at

other times during the day cannot be

assured.

Purpose: The Committee shall advise

and make recommendations to the

Director of the National Vaccine

Program on matters related to the

Program responsibilities.

Matters To Be Discussed: Agenda

items include: A discussion of the

National Vaccine Program Office

highlights; managed care and Medicaid:

ensuring optimal childhood

immunization; managed care and

immunization: American Association of

Health Plan vaccine promotion

activities; implementation of new

recommendations for polio

immunization; Public Broadcasting

System’s Nova Tape: Deadly Deception;

report of meeting on case studies in

vaccine research and developments

from the Cold Spring Harbor meeting;

adult immunization, Department of

Health and Human Services Work

Group; role of non-traditional providers

for adult immunization; pandemic

influenza preparedness plan; update on

personal responsibility concept paper

and leverage paper from the

Subcommittee on Immunization

Coverage; report from NVAC’s

Subcommittee on Vaccine Safety; status

of the National Vaccine Plan.

Agenda items are subject to change as

priorities dictate.

Name: NVAC Subcommittee on

Vaccine Safety and the ACCV

Subcommittee on Vaccine Safety.

Time and Date: 2 p.m.–5 p.m.,

January 13, 1997.

Place: Hubert H. Humphrey Building,

Room 425A, 200 Independence Avenue,

SW, Washington, DC 20201.

Status: Open to the public, limited

only by the space available.

Purpose: This joint NVAC/ACCV

subcommittee will review issues

relevant to vaccine safety and adverse

reactions to vaccines.

Matter to be Dicussed: The

Subcommittee will discuss an update on

the recommendations of the Task Force

on Safer Childhood Vaccines; update on

HHS/CDC response to funding on active

surveillance; update on vaccine risk

communication; and clarification of

mouse toxicity test.

Name: NVAC Subcommittee on

Immunization Coverage.

Time and Date: 2 p.m.–5 p.m.,

January 13, 1997.

Place: Hubert H. Humphrey Building,

Room 423A, 200 Independence Avenue,

SW, Washington, DC 20201.

Status: Open to the public, limited

only by the space available.

Purpose: This subcommittee will

identify and propose solutions that

provide a multifaceted and holistic

approach to reducing barriers that result

in low immunization coverage for

children.

Matters to be Discussed: The

Subcommittee will discuss the forum on

assessment and related immunization

issues; the outline for the

Subcommittee’s report; and the

assessment of immunization coverage.

Name: NVAC Subcommittee on

Future Vaccines.

Time and Date: 2 p.m.–5 p.m.,

January 13, 1997.

Place: Hubert H. Humphrey Building,

Room 405A, 200 Independence Avenue,

SW, Washington, DC 20201.

Status: Open to the public, limited

only by the space available.

Purpose: This subcommittee will

develop policy options and guide the

National Vaccine Program activities

which will lead to accelerated

development, licensure, and best use of

new vaccines in the simplest possible

immunization schedules.

Matters to be Discussed: The

Subcommittee will discuss an update on

vaccine procurement strategies and case

studies in vaccine development. This

notice is being published less than 15

days prior to the meeting due to

programmatic issues that had to be

resolved.

CONTACT PERSON FOR MORE INFORMATION:

Felecia D. Pearson, Committee

Management Specialist, National

Vaccine Program Office, CDC, 1600

Clifton Road, NE, M/S D50, Atlanta,

Georgia 30333, telephone 404/639–

7250.

Dated: January 3, 1997.

Joseph E. Salter,

Acting Director, Management Analysis and

Services Office Centers for Disease Control

and Prevention (CDC).

[FR Doc. 97–461 Filed 1–6–97; 11:53 am]

BILLING CODE 4163–18–P

Health Resources and Services

Administration

Agency Information Collection

Activities: Proposed Collection:

Comment Request

In compliance with the requirement

of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995 for

opportunity for public comment on

proposed data collection projects, the